Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A comparison of the efficacy of Symbicort [budesonide/formoterol] single inhaler therapy (Symbicort Turbuhaler 160/4.5 mg 1 inhalation b.i.d. plus as-needed) and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults. A randomized, open, parallel-group, multicentre 26-weeks study

Next Previous
X
Search
Trial Profile

A comparison of the efficacy of Symbicort [budesonide/formoterol] single inhaler therapy (Symbicort Turbuhaler 160/4.5 mg 1 inhalation b.i.d. plus as-needed) and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults. A randomized, open, parallel-group, multicentre 26-weeks study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2011

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Antiasthmatics
  • Indications Asthma
  • Focus Therapeutic Use

    • Most Recent Events

    • 21 Jan 2011 Trial phase changed from III to IV as reported by ClinicalTrials.gov.
    • 07 Oct 2008 Results were reported at the Annual Congress of the European Respiratory Society.
    • 07 Oct 2008 Primary endpoint 'Time to exacerbation of symptoms' has been met.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top